Nobilis Health Corp.
NRTSF · OTC
12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |
|---|---|---|---|---|
| Revenue | $299,717 | $285,744 | $229,216 | $84,029 |
| % Growth | 4.9% | 24.7% | 172.8% | – |
| Cost of Goods Sold | $112,685 | $109,785 | $78,210 | $23,228 |
| Gross Profit | $187,032 | $175,959 | $151,006 | $60,801 |
| % Margin | 62.4% | 61.6% | 65.9% | 72.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $150,718 | $157,474 | $111,112 | $38,325 |
| SG&A Expenses | $150,718 | $157,474 | $111,112 | $38,325 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $6,547 | $2,970 | -$34 | -$571 |
| Operating Expenses | $162,321 | $166,306 | $115,799 | $40,448 |
| Operating Income | $22,309 | $10,038 | $31,650 | $20,833 |
| % Margin | 7.4% | 3.5% | 13.8% | 24.8% |
| Other Income/Exp. Net | $972 | $1,551 | $9,087 | -$709 |
| Pre-Tax Income | $23,281 | $11,589 | $40,737 | $19,782 |
| Tax Expense | $13,000 | $4,487 | -$23,196 | $13,063 |
| Net Income | $3,797 | $6,449 | $50,840 | $6,720 |
| % Margin | 1.3% | 2.3% | 22.2% | 8% |
| EPS | 0.05 | 0.08 | 0.76 | 0.14 |
| % Growth | -37.5% | -89.5% | 442.9% | – |
| EPS Diluted | 0.05 | 0.08 | 0.68 | 0.14 |
| Weighted Avg Shares Out | 77,853 | 76,453 | 67,015 | 46,518 |
| Weighted Avg Shares Out Dil | 78,189 | 77,562 | 75,233 | 48,781 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $6,007 | $3,999 | $1,597 | $0 |
| Depreciation & Amortization | $11,603 | $8,832 | $4,687 | $1,642 |
| EBITDA | $34,212 | $19,170 | $36,337 | $21,996 |
| % Margin | 11.4% | 6.7% | 15.9% | 26.2% |